Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 5.16
+0.18 (3.61%)
May 11, 2026, 1:10 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 252.81 million as of May 8, 2026.
Market Cap
252.81M
Enterprise Value
242.46M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.16
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 252.81M, an increase of 66.32%. That is a compound annual growth rate of 81.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 252.81M | 53.14% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 477.55M |
| Racura Oncology | 459.45M |
| Starpharma Holdings | 303.23M |
| Orthocell | 231.97M |
| Actinogen Medical | 168.80M |
| Recce Pharmaceuticals | 144.59M |
| Nyrada | 135.95M |
| Dimerix | 129.09M |